chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7 days post vaccine, 03/19/2021 I woke up and felt funny, checked my pulse, it was very irregular, and it was jumping around. Otherwise, I felt fine. I called my doctor the next day and I made an appointment to see him in 10 days. I had been in A-fib for 10 days. They could not work me in that morning 04/07/2021.  So, the next morning 04/08/2021 they did the cardioversion at the Hospital at the atrial fibrillation lab.  I went back for a follow up 2 weeks after the cardioversion with the cardiologist and he did another EKG. It did not show I had A-Fib, and he put me on Eliquis for the rest of my life. Taking this medication has affected my life. It has put my life at risk because of bleeding possibilities. I have to change my activities because of the risk of bleeding from the blood thinners.     On occasion I have had short version of it. I don't believe I have recovered from A-fib. I am on Eliquis for the rest of my job. My cardiologist suggested I should not get the 2nd dose. I never had A-fib before. I ran marathons, played softball, raced cars. Never in my life did I have A-fib before until 1 week after the 1st dose of Pfizer.
Sore throat; Bumps on tongue; Not feeling good at all; Shoulder and arms hurt really bad; Shoulder and arms hurt really bad; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), TONGUE DISORDER (Bumps on tongue), MALAISE (Not feeling good at all), PAIN IN EXTREMITY (Shoulder and arms hurt really bad) and ARTHRALGIA (Shoulder and arms hurt really bad) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seizures and Blood pressure high. Concomitant products included AMLODIPINE and ENALAPRIL for Blood pressure high, ACETYLSALICYLIC ACID (ASPIRIN 81) for Cardiac disorder, GABAPENTIN (GABAPENTINE) for Seizures.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), TONGUE DISORDER (Bumps on tongue), MALAISE (Not feeling good at all), PAIN IN EXTREMITY (Shoulder and arms hurt really bad) and ARTHRALGIA (Shoulder and arms hurt really bad). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), TONGUE DISORDER (Bumps on tongue), MALAISE (Not feeling good at all), PAIN IN EXTREMITY (Shoulder and arms hurt really bad) and ARTHRALGIA (Shoulder and arms hurt really bad) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Pt t103.0 ax in ER; pts mom stated pt had some muscle spasms & jerking in arms, legs & trunk; mom states pt was fussy most of noc; MD said alternate hosp pediatric advil w/tempra;
On the way home after receiving the vaccine, I was driving and noticed that the left side of my face went numb around my upper lip, nose and jaw area. It felt like the same sensation as getting numbed for dental work. I called my doctor and was advised to monitor my symptoms and to seek medical care if they get worse. It lasted for 3 days. I did not receive any further medical care.
On 7/6/06, a 4 year old female patient received a 0.5ml IM DTaP immunization in the left thigh and experienced red lesions on the left medial thigh at the injection site the next day (7/7/06). By 7/9, the area had become tender to the touch, and a 4-5 cm halo with blisters at the lower edge of the halo had appeared. The patient also received a 0.5ml IM Hepatitis A vaccination at another site on the left thigh; however, no lesions were noted in that area. She was started on Orapred® 30mg daily x 5 days on 7/10. The mother subsequently reported that the blisters resolved; she was told to return to the clinic if there are any further concerns. It is unknown how many previous doses of vaccine the patient has received, or what the other 2 vaccinations (1 in right arm, 1 in left arm) were; the notes did not reveal what vaccination was given in these areas.
Fever, body aches, fatigue & local soreness in deltoid. Missed 1 duty day due to adverse reaction.
Extreme anxiety, Inability to sleep for more than 3-4 hours at a time even tho prior to the vaccination she was sleeping 8-10 hours/night straight through.
The patient did not have a reaction of any kind until 10/14/19.  Upon waking, the patient noticed a rash on her arms, under her armpit on the left side, and down her rib cage on the left side.  As the day progresses, the patient reports the rash is moving down her torso and legs.  The patient describes the rash and large, red, splotches that are hot to the touch.  She states she did not have any reaction following the first Shingrix administered on 6/27/19.
Sensation of 'pins and needles' L arm and hand, decreased sensation to touch from shoulder to hand. Pulse regular 100 skin warm and dry, blanches, full ROM, normal strength; inj - on redness, describes pain at inj site as a 6-7 out of 10. Mother notified.
Headache, Sedation, Myalgia, Arthralgia, Fever,  NauseaVomiting, chills, muscle cramps Narrative:
The pharmacist injected too high on my shoulder. The second the injection occurred it felt like FIREY PAIN being injected into my shoulder. I have never experienced this pain or feeling from a shot, and I've had many. It hurt immediately and hasnt stopped hurting, as I type this, 6 weeks later.   I visited an Urgent care 2 weeks after due to the severe pain and concerns something was serious. They ruled out infections but otherwise basically sent me packing.   Today I went to the ER as the pain has increased slightly the past few days. They diagnosed suspected rotator cuff tear worst case, or SIRVA best case. I'm scheduled to have an MRI after already having X RAYs done today at the ER. They also prescribed a strong anti-inflammatory medicine and muscle relaxer to take daily.  I have done PT on my own since the injury with little progress.   Current state is severe pain doing rotator cuff movements.
Sore shoulder- localized to left arm; Body aches; Tired; This is a spontaneous report from a contactable consumer (patient). A 46-years-old male patient received second dose bnt162b2 (BNT162B2), Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 01Feb2021 at 16:30 as 2ND DOSE, SINGLE DOSE for COVID-19 immunization. The patient was 46-years-old at the time of vaccination. The patient previously received first dose of BNT162B2 (Lot Number: unknown) dose 1 via an unspecified route of administration, administered in Arm Left  12Jan2021 at 09:30 AM for COVID-19 immunization. Patient relevant medical history included high blood pressure. The patient concomitant medication(s) included valsartan (DIOVAN) taken for an unspecified indication. It was reported that on 02Feb2021 at 18:00, the patient experienced sore shoulder- localized to left arm, body aches, tired. On unspecified date, the patient underwent lab tests and procedures which included blood pressure measurement was high. The outcome of event was recovered.  Information about batch/lot number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Site: Pain at Injection Site-Mild, Systemic: patient stated \"palpitations\"-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: Patient received Janssen covid vaccine 3/12/21 at 5:04pm to her left arm. Due to patient's response on the screening questions, patient was to be observed for 30 min. At 5:30pm patient complained of numbness to arms and face. At 5:34pm patient state she had palpitations. Rph on duty advised husband to take her to ER asap. For next 3days, rph on duty attempted to call the patient multiple times throughout the day but the phone would go straight to busy signal.
Itching on neck that progressed from one side to the other.  PHN administered 25 mg benadryl PO.  Patient reported lessening of itching.  Patient sent home in stable condition with no further symptoms.
pt recognized @ daycare to be apneic sent to hosp where declared deceased SIDS;
got sick every year she got it; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 03-DEC-2020.  This case involves a female patient of unknown age who got sick every year she got it (illness), while she received vaccine Influenza Vaccine.   The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, it was reported that never got the shot, never will. His ex got sick every year she got it, until he convinced her mot to. Has not got sick since she stopped getting the shot (illness).  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.  The reporter assessed the causal relationship with suspect vaccine as related.
This is a spontaneous report received from a contactable consumer (patient). A 26-year-old female patient (not pregnant) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 26, in left arm, on Feb 4, 2021, at 12:00, single dose, for COVID-19 immunisation. The patient's medical history not reported. Concomitant medication included Prozac. The patient had  pain in extremity/sore arm, fatigue and headache, onset Feb 4, 2021, at 20:00, outcome of recovering. No therapeutic measures taken as a result of pain in extremity, fatigue and headache. Additional information: The patient received dose #2 on Feb 25, 2021, at 09:30 am. Vaccine location: Left arm. The patient did not have COVID-19 prior vaccination. The patient has not tested post vaccination. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
elevated BCR-ABL after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PHILADELPHIA CHROMOSOME POSITIVE (elevated BCR-ABL after vaccine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history was not provided.  Concurrent history include leukemia (CML)  On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 09-Mar-2021, the patient experienced PHILADELPHIA CHROMOSOME POSITIVE (elevated BCR-ABL after vaccine) (seriousness criterion medically significant). The patient gets routine blood drawn and it was elevated .   At the time of the report, PHILADELPHIA CHROMOSOME POSITIVE (elevated BCR-ABL after vaccine) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.      No treatment details were provided.; Sender's Comments: Based on the information provided, a causal association between the event of elevated BCR-ABL  and the administration of the vaccine is assessed as not related.  Event is inherent to the nature of the underlying malignancy.  Patient has a history of leukemia.
Patient had extreme arm soreness the day after vaccine and then developed a rash on 5/25 (original shot on 5/18/21). This rash is accompanied by some itching.
Information has been received from a 24 year old female, for the Pregnancy Registry for GARDASIL, concerning the 24 year old female who in December 2007, was vaccinated intramuscularly with the first dose of GARDASIL and in June 2008, was vaccinated intramuscularly with the third 0.5 ml dose of GARDASIL. There was no concomitant medication. The patient was two weeks pregnant while receiving the third dose of GARDASIL. The pregnancy test was positive. Unspecified medical attention was sought. Follow-up information on 01-JUL-2009 was received from an other healthy professional who reported that the patient with a history of 1 pregnancy and 1 live birth was vaccinated intramuscularly with the first dose of GARDASIL on 03-DEC-2007, on 04-FEB-2008, was vaccinated intramuscularly with the second dose of GARDASIL vaccine (lot # 655327/1287U) and on 04-JUN-2008, was vaccinated intramuscularly with the third dose of GARDASIL (lot # 655604/0052X). On 23-SEP-2008, ultrasound was performed with normal result. On 15-OCT-2008, maternal serum alpha-fetoprotein (MSAFP) was performed with negative result. On 13-FEB-2009 (Weeks from LMP: 39), the patient delivered a male infant with congenital anomaly cleft palate, weight: 8 lbs 3 oz and Apgar score 8/9. As of 01-JUL-2009, the outcome of cleft palate was unknown. Additional information has been requested.
This spontaneous report received from a patient, concerned a patient of unspecified age and gender. Medical history, weight, height, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch/lot number: not reported) dose: not reported, on Mar 12, 2021, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced low antibodies. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome of low antibodies: not reported.
After vaccine,  went to car, she felt a hot flash and reported dizziness, she then for about 15-20 seconds had seizure like activity, pharmacist aware and pediatrician notified to which it is believed it was a vasovagal response.   felt confused after the event with a headache, otherwise no other reaction at this time.
covid infection post vaccination; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (covid infection post vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid infection post vaccination). At the time of the report, COVID-19 (covid infection post vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information provided. The patient received first vaccine, then was exposed and got Covid, was no longer under quarantine.  This is a regulatory authority case concerning  a patient or unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred approximately on an unknown day after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: This is a regulatory authority case concerning  a patient or unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred approximately on an unknown day after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
Pt. was given the flu vaccine on admission to the hospital as part of their admission assessment procedure on 2/15/2018. Guillain-Barre syndrome was diagnosed on 2/27/2018, treated with IV fluids, IVIG, steroids.
6 days after dose #2 of Pfizer Covid Vaccine, I experienced  systemic body itch. I took benadryl  and Claritin for the itching over the next 3 days.  There was no visible rash, just a relentless itch all over my body.
Axillary pain; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Axillary pain) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Axillary pain). At the time of the report, AXILLARY PAIN (Axillary pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.
patient received an improperly stored vaccine; This spontaneous report as received from a medical assistant refers to a currently 5 year old female patient. On an unknown date, the patient was vaccinated with a 0.5 mL dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T025221 exp date 19-JAN-2022) (route not reported) first identified on 28-DEC-2020. There was a data logger issue reported. The temperature of excursion was -6.7 °C for a time frame of 22 hours. There was no previous temperature of excursion.
patient came into pharmacy and requested by name, prevnar 13.  to finish his series because 1 year ago he received pneumovax 23.  the series is out of sequence.  however this is what he requsted.  as per the new guidleline, prevnar 20 should have been used,   we contacted the patient and the physican.  they are ok with it .  and the md said that the series is now complete.  not more vaccinations are needed
arm became tender; little swollen; itchy; red; my arm was rrally paijful; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm was rrally paijful), TENDERNESS (arm became tender), PERIPHERAL SWELLING (little swollen), PRURITUS (itchy) and ERYTHEMA (red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (my arm was rrally paijful), TENDERNESS (arm became tender), PERIPHERAL SWELLING (little swollen), PRURITUS (itchy) and ERYTHEMA (red). At the time of the report, PAIN IN EXTREMITY (my arm was rrally paijful), TENDERNESS (arm became tender), PERIPHERAL SWELLING (little swollen), PRURITUS (itchy) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.   Reporter did not allow further contact
This spontaneous report as received from a physician refers to a patient of unknown demographics. Information about patient's medical history was not provided. On 13-MAR-2015, the patient was vaccinated with a dose of ZOSTAVAX (dose: 0.65 ml, frequency, indication and lot # were not specified, subcutaneously) instead of VARIVAX (Merck). No adverse event was reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Vaccinated with moderna in March 2021. Has sore throat, runny nose and headache.
Mild rash - on day11 after vaccine 2mm papules on abd, back & (R) wrist. No fever, no malaise.
I am having numbness and tingling effect in my left arm where I had the shot. But only happen about 5 days ago. Its more than a month since the shot.; I am having numbness and tingling effect in my left arm where I had the shot. But only happen about 5 days ago. Its more than a month since the shot.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 17May2021 at 09:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not reported if the patient received any other vaccines within four weeks prior to the vaccination. On 15Jun2021, the patient was having numbness and tingling effect in his left arm where he had the shot. But only happened about five days before the report. It was more than a month since the shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events having numbness and tingling effect in left arm where the patient had the shot was not resolved at the time of this report.
local discomfort day 1 & 2;local heat & erythema day 3 & 4;local heat & erythema resolved day 5, but onset of scattered urticaria which resolved spontaneously w/in 6hr w/o any tx;
Information has been received from a pharmacist via a company representative referring to a patient of unknown age and gender. The patient was immunosuppressed (cause was unknown). On an unknown date the patient was vaccinated with a shot of ZOSTAVAX (lot# and expiration date were unknown) subcutaneously. After vaccination, the patient developed shingles and was subsequently hospitalized. The patient was hospitalized for three weeks at an unspecified facility. The event of shingles was improved on therapy. It was also reported that the patient received the vaccine from an unknown doctor, who was aware of the patient's immunosuppressed status (medication error). Additional information is not expected as there was no consent for follow up.